Ribozyme and omics

Anti-cancer development based on RNA Platform technology Core competence to meet diverse unmet medical needs

Core Technology

RNA replacement enzyme-based cancer gene therapy technology (1st indication: Advanced HCC)

Mechanism of RNA replacement enzyme

Excellency
  • Specific regression of liver cancer cells expressing target RNAs & Specificity enhance by use of pro-drug
  • Efficacy enhancement by suppressing target RNA expression & simultaneously triggering therapeutic gene expression in target cells
  • Optimization of vector dose and minimization of side effects in non-tumor hepatocytes via miRNA regulation